Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

A LEAP of Faith

| Angus Stewart | 6 min read

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Business & Regulation Profession

Demystifying Cancer R&D

| Maryam Mahdi | 5 min read

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Discovery & Development Clinical Trials

Video: How Can Pharma Improve Clinical Trials?

| Maryam Mahdi

How pharma is working to develop efficient and patient-centric trials.

Discovery & Development Clinical Trials

The Cancer Trial Seeing Incredible Results

| Stephanie Sutton | 2 min read

A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

Discovery & Development Clinical Trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Discovery & Development Clinical Trials

Trials on Trial

| Angus Stewart

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Business & Regulation Standards & Regulation

Addressing the Aduhelm Controversy

| Stephanie Sutton

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

Business & Regulation Trends & Forecasts

The Magnificent Seven

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

Discovery & Development Clinical Trials

Meet the Microbiome Matchmaker

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

Discovery & Development Clinical Trials

Keeping It Real

| Karen Ooms

Why the industry needs to finally wake up to the real-life benefits of real-world data.


Latest White Papers

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register